Selected for the Osaka Innovation Hub “OIH GLOBAL BRIDGE” Program

FerroptoCure Co., Ltd. (Representative Director: Yuji Otsuki) is pleased to announce that it has been selected as a participating startup in the “OIH GLOBAL BRIDGE” program, a global expansion support initiative organized by the Osaka Innovation Hub (OIH).

“OIH GLOBAL BRIDGE” is a program designed for startups with innovative technologies and research achievements, providing hands-on support for business growth and assistance in creating new business opportunities. Focusing on the bio/life sciences, green tech, and digital sectors, the program leverages networks with overseas companies, investors, and support organizations to help create opportunities for pilot testing, business partnerships, fundraising, and sales channel development in overseas markets. In addition, selected companies receive tailored support based on their business phase and challenges, helping to facilitate and accelerate their global expansion.

Taking this selection for “OIH GLOBAL BRIDGE” as an opportunity, we will further advance our efforts to create new collaboration opportunities and drive business growth. We will leverage the insights and networks gained through this program to accelerate our research and development as well as commercialization. As a leading company in ferrotosis-based drug discovery, we will continue to deliver new treatment opportunities to patients with intractable cancers and strive to realize a “world free from the suffering of cancer.”

関連記事：OIH GLOBAL BRIDGE
関連ページ　Science